FdaApplication
NDA 217581
Identifiers
- fda_app_no: NDA217581
Properties
| Property | Value |
|---|---|
| applicant_name | PF PRISM CV |
| application_type | NDA |
| approval_date | 2023-09-07 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XALKORI | CRIZOTINIB | 150MG | CAPSULE, PELLETS;ORAL |
| XALKORI | CRIZOTINIB | 20MG | CAPSULE, PELLETS;ORAL |
| XALKORI | CRIZOTINIB | 50MG | CAPSULE, PELLETS;ORAL |
3 products